Rajnish Wellness reports FY26 net loss of ₹62.87 crore; files newspaper clippings with BSE
Rajnish Wellness Limited reported a net loss of ₹62.87 crore for FY26 against a net profit of ₹1.73 crore in the prior year, with revenue from operations rising sharply to ₹1,417.52 crore from ₹485.61 crore. Total expenses of ₹1,509.90 crore exceeded total income of ₹1,425.76 crore, and the auditor flagged a ₹9.70 crore write-off of irrecoverable sundry debtors. The company subsequently filed newspaper clippings of its audited results with BSE on June 01, 2026, under Regulation 47 of SEBI LODR Regulations.

*this image is generated using AI for illustrative purposes only.
Rajnish Wellness Limited reported a net loss of ₹62.87 crore for the financial year ended March 31, 2026, compared to a net profit of ₹1.73 crore in the previous year. Revenue from operations for the year surged to ₹1,417.52 crore from ₹485.61 crore in the previous year. The board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026. Subsequently, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted newspaper clippings of its audited financial results to BSE Limited on June 01, 2026. The results were published in Active Times (English edition) and Mumbai Lakshadeep (Marathi edition).
For the quarter ended March 31, 2026, the company reported a net loss of ₹4.69 crore on revenue from operations of ₹101.94 crore. The statutory auditor, Motilal & Associates LLP, issued an unmodified opinion on the financial results. However, the auditor drew attention to a material write-off of sundry debtors amounting to ₹9.70 crore during the year, as the management assessed these balances as irrecoverable.
Total income for FY26 stood at ₹1,425.76 crore, while total expenses increased to ₹1,509.90 crore. The company's paid-up equity share capital was ₹101.53 crore as of March 31, 2026. Basic earnings per share for the year were (₹0.06), compared to ₹0.00 in the previous year. The board of directors did not recommend any dividend for the financial year 2025-26. The company operates in a single segment, Pharmaceuticals & FMCG, and there were no investor complaints received during the quarter and year ended March 31, 2026.
Financial Highlights for FY26
The table below presents the key financial metrics for Rajnish Wellness for the year and quarter ended March 31, 2026, compared to the previous year.
| Particulars: | Year Ended Mar 31, 2026 (₹ in Lakhs) | Year Ended Mar 31, 2025 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations: | 14,175.23 | 4,856.11 |
| Total Income: | 14,257.62 | 4,908.49 |
| Total Expenses: | 15,099.00 | 4,885.20 |
| Net Profit/(Loss) for the Period: | (628.72) | 17.30 |
| Basic EPS: | (0.06) | 0.00 |
Regulatory Compliance
The financial results are prepared in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The trading window for dealing in the company's securities, which closed on April 01, 2026, will reopen 48 hours after the declaration of the audited financial results on the stock exchange. The newspaper clipping submission was signed by Managing Director Rajnishkumar Singh (DIN: 07192704) on June 01, 2026.
Historical Stock Returns for Rajnish Wellness
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.22% | -2.22% | -12.00% | -34.33% | -53.19% | +158.82% |
What specific factors drove the nearly three-fold surge in revenue despite the shift to a net loss?
How does the company plan to address the material write-off of sundry debtors and improve credit recovery mechanisms?
What measures will be implemented to control the significant rise in total expenses relative to revenue growth?































